APA (7th ed.) Citation

Liu, X., Zha, Y., Wang, Z., Jiang, Y., Zhang, X., Guo, J., . . . Tsao, E. (2025). The pharmacokinetics and safety comparison of Zamerovimab and Mazorelvimab monoclonal antibodies vs. HRIG in category III rabies post-exposure prophylaxis: A stratified analysis by wound characteristics. Biologicals, 92, 101852. https://doi.org/10.1016/j.biologicals.2025.101852

Chicago Style (17th ed.) Citation

Liu, Xiaoqiang, Yongxian Zha, Zhengxiong Wang, Ya Jiang, Xiangyu Zhang, Jiangshu Guo, Jingyu Li, Qingchao Zhang, and Eric Tsao. "The Pharmacokinetics and Safety Comparison of Zamerovimab and Mazorelvimab Monoclonal Antibodies Vs. HRIG in Category III Rabies Post-exposure Prophylaxis: A Stratified Analysis by Wound Characteristics." Biologicals 92 (2025): 101852. https://doi.org/10.1016/j.biologicals.2025.101852.

MLA (9th ed.) Citation

Liu, Xiaoqiang, et al. "The Pharmacokinetics and Safety Comparison of Zamerovimab and Mazorelvimab Monoclonal Antibodies Vs. HRIG in Category III Rabies Post-exposure Prophylaxis: A Stratified Analysis by Wound Characteristics." Biologicals, vol. 92, 2025, p. 101852, https://doi.org/10.1016/j.biologicals.2025.101852.